(Reuters) – Merck & Co Inc (MRK.N) said on Monday it has applied for U.S. emergency use authorization for its drug to treat mild-to-moderate patients of COVID-19, putting it on course to…
Trending News
April 5, 2026
April 5, 2026
April 5, 2026
April 5, 2026





